3 results
To evaluate the tumor targeting performance of the human radiolabeled antibody 124I-F16SIP.To investigate pharmacokinetics/-dynamics of 124I-F16SIP, and to assess its uptake in tumor and normal tissues as obtained from the surgical specimen.
The objective of this pivotal study is to assess the long-term safety, tolerability, pharmacokinetics and pharmacodynamics of RP103 in pediatric and adult patients with nephropathic cystinosis. Results of this Phase 3 study will be used to support…
In this pilot study we have technical/methodological questions: we want to confirm the envisioned kinetic profiles of stable isotope tracers 13C-labelled SCFA delivered by catheter in 5 subjects, and to establish the time points of plasma sampling (…